Philips Recalls Faulty Ventilators, FDA Identifies Dust Issue As ‘Most Serious’
Koninklijke Philips N.V. (NYSE: PHG) is recalling several ventilators after detecting dust and dirt from the environment in the air path
FDA Approves Pfizer’s Blood Cancer Therapy For Heavily Pretreated Patients
The FDA granted accelerated approval to Pfizer Inc's (NYSE: PFE) Elrexfio (elranatamab-bcmm) for adult patients with relapsed or refractory multiple myeloma (RRMM) who have received at
Pfizer’s ELREXFIO Receives U.S. FDA Accelerated Approval For Relapsed Or Refractory Multiple Myeloma
The approval of ELREXFIO (elranatamab-bcmm) is based on clinically meaningful response rates and duration of response from Phase 2 MagnetisMM-3 study
ELREXFIO is the first off-the-shelf (ready-to-use) fixed-dose
ENDRA Life Sciences Submits De Novo Request For Its TAEUS System Liver Fat Application To The U.S. FDA
Announces Positive Topline Data from Clinical Studies Comparing TAEUS with MRI-PDFF
ENDRA Life Sciences Inc.(NASDAQ:NDRA), a pioneer of imaging technologies and Thermo Acoustic Enhanced UltraSound (TAEUS®),
FDA Accepts MyMD Pharmaceuticals’ Investigational New Drug Application For Phase 2 Study Of Oral TNF-α Inhibitor MYMD-1 In Rheumatoid Arthritis
- Next-generation and first oral TNF-α inhibitor, which completed Phase 2 study for age-related condition sarcopenia, represents a potentially groundbreaking advance in the treatment of RA and disruption of
Ra Medical Systems Announces Allowance Of New Closure Device Patent; First Patent Out Of Six Applications On File For LockeT Product
First patent out of six applications on file for LockeT product
FORT MILL, SC / ACCESSWIRE / August 14, 2023 / Ra Medical Systems, Inc. (NYSE:RMED) today announced that it has received notification of
Why Is Galera Therapeutics Stock Sinking Today?
The FDA issued a Complete Response Letter (CRL) to Galera Therapeutics Inc's (NASDAQ: GRTX) New Drug Application (NDA) for avasopasem manganese (avasopasem) for radiotherapy-induced severe oral mucositis (SOM) in patients with head and neck cancer undergoing
Galera Receives Complete Response Letter From U.S. FDA for Avasopasem Manganese; The Co Intends To Request A Type A Meeting With The FDA To Understand The FDA’s Rationale For Its Decision
The Company remains committed to its goal of bringing avasopasem to patients and intends to meet with FDA as soon as possible to discuss potential next steps
Galera will take actions to extend its cash runway and
Terns Achieves Primary Endpoint And All Secondary Endpoints In Phase 2a DUET Trial Of THR-β Agonist TERN-501 In NASH
TERN-501 demonstrated dose dependent MRI-PDFF reductions at Week 12 as a once-daily, low dose, and combinable oral therapy
TERN-501 (6mg) showed statistically significant mean relative liver fat content reduction
Boston Scientific Receives FDA Approval For The POLARx Cryoablation System
First-of-its-kind expandable cryoballoon catheter advances cryoablation therapy, addresses key limitations with traditional systems
MARLBOROUGH, Mass., Aug. 8, 2023 /PRNewswire/ -- Boston Scientific